The role of Plk3 in oncogenesis (Q38444150)

3 September 2017

1 reference

title

The role of Plk3 in oncogenesis (English)

1 reference

3 September 2017

C Helmke

1

1 reference

3 September 2017

S Becker

series ordinal

2

1 reference

3 September 2017

K Strebhardt

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

27 April 2015

1 reference

3 September 2017

1 reference

3 September 2017

35

1 reference

3 September 2017

2

1 reference

3 September 2017

135-147

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2015.105

3 September 2017

0 references

cites work

Paul Ehrlich's magic bullet concept: 100 years of progress.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Molecular targets for breast cancer therapy and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Microtubules and resistance to tubulin-binding agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

polo encodes a protein kinase homolog required for mitosis in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases: conservation and divergence in their functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases: structural variations lead to multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

From Plk1 to Plk5: functional evolution of polo-like kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases: a team in control of the division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases and the orchestration of cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Current assessment of polo-like kinases as anti-tumor drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

PLK1 as an oncology target: current status and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinases in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Phosphorylation of synucleins by members of the Polo-like kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Human Prk is a conserved protein serine/threonine kinase involved in regulating M phase functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase 3 is required for entry into S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Microarray analysis of radiation response genes in primary human fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Profiles of global gene expression in ionizing-radiation-damaged human diploid fibroblasts reveal synchronization behind the G1 checkpoint in a G0-like state of quiescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FONC.2015.105

21 January 2018

12 December 2020

The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Sequestration of Polo kinase to microtubules by phosphopriming-independent binding to Map205 is relieved by phosphorylation at a CDK site in mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Functional studies on the role of the C-terminal domain of mammalian polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Structural basis for the inhibition of Polo-like kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Bora and Aurora-A continue to activate Plk1 in mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

SysPTM: a systematic resource for proteomic research on post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Activation of Polo-like kinase 3 by hypoxic stresses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Stress-induced c-Jun activation mediated by Polo-like kinase 3 in corneal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Unravelling mechanisms of p53-mediated tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Investigation on PLK2 and PLK3 substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle progression and checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Rapid destruction of human Cdc25A in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

21 January 2018

The Plk3-Cdc25 circuit

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The physical association and phosphorylation of Cdc25C protein phosphatase by Prk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Control of cell cycle progression by c-Jun is p53 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Regulation of PTEN stability and activity by Plk3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The in vivo gene expression signature of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The impact of O2 availability on human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

The PTEN-PI3K pathway: of feedbacks and cross-talks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Hyperosmotic stress-induced corneal epithelial cell death through activation of Polo-like kinase 3 and c-Jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

mRNA turnover rate limits siRNA and microRNA efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Progress in the discovery of polo-like kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Crystal structure of the polo-box domain of polo-like kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

A pan-specific inhibitor of the polo-box domains of polo-like kinases arrests cancer cells in mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Role of Plk2 (Snk) in mouse development and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Polo-like kinase-1 is a target of the DNA damage checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Prognostic value of pololike kinase expression in melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Identification of novel p53 target genes in ionizing radiation response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: self- versus non-self-priming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

mRNA turnover rate limits siRNA and microRNA efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.105

Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer

31 March 2020

1 reference

12 December 2020

Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Radiation dose effect of DNA repair-related gene expression in mouse white blood cells

1 reference

12 December 2020

Murine FGF-inducible kinase is rapidly degraded via the nuclear ubiquitin-proteosome system when overexpressed in NIH 3T3 cells.

1 reference

12 December 2020

polo, a mitotic mutant of Drosophila displaying abnormal spindle poles.

1 reference

12 December 2020

Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation

1 reference

12 December 2020

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy

1 reference

12 December 2020

Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma

1 reference

12 December 2020

Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.

1 reference

12 December 2020

The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation

1 reference

12 December 2020

Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2015.105

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference